Benzodioxanyl-hydroxyethyleneamino-piperidinyl acetanilides, ketones, esters and carbamates which effect immunity and calcium entry and .beta.-blockade
First Claim
1. A compound of the formula:
- ##STR18## or a pharmaceutically acceptable acid addition salt thereof, wherein;
R1, R2, R3 and R4 are each independently hydrogen, lower alkyl, lower alkoxy, trifluoromethyl, halo, lower alkylthio, lower alkyl sulfinyl or lower alkyl sulfonyl;
R5 is hydrogen or lower alkyl;
m is 0 or 1;
W is alkylene, --CH═
CH--, --O--, or --N(R6)--, where R6 is lower alkyl or hydrogen;
n is 0 or 1; and
Q is lower alkyl, cycloalkyl of 3-8 carbon atoms or optionally substituted phenyl of the formula ##STR19## wherein each of R7, R8, R9, R10 and R11 is independently chosen from hydrogen, lower alkyl, lower alkoxy, trifluoromethyl, halo, lower alkylthio, lower alkyl sulfinyl or lower alkyl sulfonyl, aminosulfonyl or hydroxyl or R8 and R9 together form a --OCH2 O-- linkage.
1 Assignment
0 Petitions
Accused Products
Abstract
Novel compounds of the general formula: ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein: R1, R2, R3 and R4 are each independently hydrogen, lower alkyl, lower alkoxy, trifluoromethyl, halo, lower alkylthio, lower alkyl sulfinyl or lower alkyl sulfonyl;
R5 is hydrogen or lower alkyl;
m is 0 or 1;
W is alkylene, --CH═CH--, --O--, or --N(R6)--, where R6 is lower alkyl or hydrogen;
n is 0 or 1; and
Q is lower alkyl, cycloalkyl or optionally substituted phenyl.
These compounds combine β-blockade and calcium entry blockade properties in the same compound and therefore are useful in therapy in the treatment of cardiovascular diseases, including myocardial infarction, hypertension, arrhythmia and variant and exercise induced angina. The compounds are also useful in immunosuppressant therapy for immune diseases, such as rheumatoid arthritis.
-
Citations
49 Claims
-
1. A compound of the formula:
- ##STR18## or a pharmaceutically acceptable acid addition salt thereof, wherein;
R1, R2, R3 and R4 are each independently hydrogen, lower alkyl, lower alkoxy, trifluoromethyl, halo, lower alkylthio, lower alkyl sulfinyl or lower alkyl sulfonyl;R5 is hydrogen or lower alkyl; m is 0 or 1; W is alkylene, --CH═
CH--, --O--, or --N(R6)--, where R6 is lower alkyl or hydrogen;n is 0 or 1; and Q is lower alkyl, cycloalkyl of 3-8 carbon atoms or optionally substituted phenyl of the formula ##STR19## wherein each of R7, R8, R9, R10 and R11 is independently chosen from hydrogen, lower alkyl, lower alkoxy, trifluoromethyl, halo, lower alkylthio, lower alkyl sulfinyl or lower alkyl sulfonyl, aminosulfonyl or hydroxyl or R8 and R9 together form a --OCH2 O-- linkage. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49)
- ##STR18## or a pharmaceutically acceptable acid addition salt thereof, wherein;
Specification